Found: 30
Select item for more details and to access through your institution.
Subcutaneous Biologics: Clinical Pharmacology and Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 385, doi. 10.1002/cpt.3179
- By:
- Publication type:
- Article
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 440, doi. 10.1002/cpt.3178
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 383, doi. 10.1002/cpt.3177
- Publication type:
- Article
Subcutaneous Marzeptacog Alfa (Activated) for On‐Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 498, doi. 10.1002/cpt.3172
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 393, doi. 10.1002/cpt.3166
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 391, doi. 10.1002/cpt.3164
- Publication type:
- Article
Assessment of Quinidine‐Induced Torsades de Pointes Risks Using a Whole‐Body Physiologically Based Pharmacokinetic Model Linked to Cardiac Ionic Current Inhibition.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 616, doi. 10.1002/cpt.3156
- By:
- Publication type:
- Article
Azacitidine for Acute Myeloid Leukemia: Why One Dose Does Not Fit All.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 403, doi. 10.1002/cpt.3154
- By:
- Publication type:
- Article
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 422, doi. 10.1002/cpt.3150
- By:
- Publication type:
- Article
Model‐Based Dose Selection of Subcutaneous Nivolumab in Patients with Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 488, doi. 10.1002/cpt.3148
- By:
- Publication type:
- Article
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 565, doi. 10.1002/cpt.3147
- By:
- Publication type:
- Article
Impact of Pregnancy on the Pharmacokinetics and Metabolism of Nicotinamide in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 556, doi. 10.1002/cpt.3146
- By:
- Publication type:
- Article
Pharmacokinetics‐Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 404, doi. 10.1002/cpt.3145
- By:
- Publication type:
- Article
ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 606, doi. 10.1002/cpt.3138
- By:
- Publication type:
- Article
Blood Group Antigen A Carriers Exhibit an Extended Progression‐Free Survival with no more Immune‐Related Adverse Events.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 545, doi. 10.1002/cpt.3140
- By:
- Publication type:
- Article
Drug‐Induced Acute Pancreatitis: A Real‐World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 535, doi. 10.1002/cpt.3139
- By:
- Publication type:
- Article
Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 525, doi. 10.1002/cpt.3136
- By:
- Publication type:
- Article
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 412, doi. 10.1002/cpt.3133
- By:
- Publication type:
- Article
The European List of Key Medicines for Medical Education: A Modified Delphi Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 515, doi. 10.1002/cpt.3132
- By:
- Publication type:
- Article
Risk of Toxicity From Topical 5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 452, doi. 10.1002/cpt.3131
- By:
- Publication type:
- Article
Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials".
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 401, doi. 10.1002/cpt.3130
- By:
- Publication type:
- Article
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 576, doi. 10.1002/cpt.3124
- By:
- Publication type:
- Article
Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 400, doi. 10.1002/cpt.3129
- By:
- Publication type:
- Article
Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics‐Informed Relative Expression Factor Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 595, doi. 10.1002/cpt.3123
- By:
- Publication type:
- Article
The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 478, doi. 10.1002/cpt.3116
- By:
- Publication type:
- Article
Current Perspectives on Data Sharing and Open Science in Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 408, doi. 10.1002/cpt.3115
- By:
- Publication type:
- Article
Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 506, doi. 10.1002/cpt.3112
- By:
- Publication type:
- Article
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 468, doi. 10.1002/cpt.3064
- By:
- Publication type:
- Article
A Mechanistic Physiologically‐Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 457, doi. 10.1002/cpt.3056
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 375, doi. 10.1002/cpt.2940
- Publication type:
- Article